CompAI HealthCare Technology (Suzhou) Co., Ltd. was established in 2019 with a total investment of nearly 100 million yuan by the end of 2021. The company has established subsidiaries in Shenzhen, Changchun, and other cities.

In October 2020, CompAI Shenzhen entered the industry finals of the 12th China Shenzhen Innovation and Entrepreneurship Competition.

In July 2021, CompAI Medical signed a contract with Suzhou New District for its headquarters project, and the company’s headquarters officially settled in Suzhou New District. In October 2021, CompAI Suzhou entered the national high-tech enterprise incubation program. In November 2021, the CEO of the company, Peng Sheng, was selected as an entrepreneurial leader talent in Suzhou New District. In December 2021, CompAI Shenzhen was listed as a national high-tech enterprise.

In September 2022, CEO Peng Sheng was approved as a leading entrepreneur in Gusu District (Suzhou). In November 2022, CompAI Suzhou successfully entered the national high-tech enterprise list. In December 2022, CompAI Suzhou was listed as a potential unicorn enterprise in Jiangsu Province.

The company, based on independent intellectual property rights and relying on a team with rich experience in medical equipment development, adopts agile development and rapid iteration methods. It has accumulated over 50 patent and copyright applications. The first product was launched in 2020 and successfully passed testing by the internationally recognized third-party testing organization, Intertek, in the UK. The product has obtained certifications from the U.S. FDA, EU CE, and ISO 13485:2016 medical device quality management system. The product has been adopted by many top hospitals in China and internationally renowned hospitals.